Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

18.71

+0.43 (2.35%)

At close: Sep 18, 2026, 4:00 PM EDT

19.18

+0.47 (2.51%)

After-hours: Sep 18, 2026, 7:49 PM EDT

Amneal Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,118	3,019	2,794	2,394	2,212	2,094
Revenue Growth	9.28%	8.05%	16.73%	8.20%	5.67%	5.08%
Gross Profit	1,241	1,128	1,016	852.87	791.46	783.95
Operating Income	495.15	420.7	348.36	260.38	200.03	216.6
Net Income	157.36	72.06	-116.89	-83.99	-129.99	10.62
Earnings Per Share	0.48	0.22	-0.38	-0.48	-0.86	0.07
EPS Growth	4332.00%	-	-	-	-	-88.52%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Affordable Medicines Net	1,811	1,746	1,685	1,471	1,432	1,366
Specialty Net	574.73	528.51	445.75	390.46	374.12	378.32
AvKARE Net	732.28	744.73	662.95	531.75	406.11	349.01
Revenue (Total)	3,118	3,019	2,794	2,394	2,212	2,094

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	131.41	286.47	112.42	93.74	27.8	248.96
Total Debt	2,792	2,689	2,593	2,751	2,845	2,888
Net Cash (Debt)	-2,660	-2,403	-2,481	-2,657	-2,817	-2,639
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.12	-7.40	-8.03	-15.08	-18.66	-17.38

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	200.78	339.99	295.1	345.58	65.1	241.82
Capital Expenditures	-117.67	-98.84	-60.34	-46.8	-48.8	-50.94
Free Cash Flow	83.11	241.15	234.76	298.78	16.3	190.88
Free Cash Flow Growth	-69.32%	2.72%	-21.43%	1732.42%	-91.46%	-39.82%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	39.81%	37.38%	36.35%	35.63%	35.77%	37.44%
Operating Margin	15.88%	13.94%	12.47%	10.88%	9.04%	10.35%
Pretax Margin	6.45%	4.61%	-1.97%	-1.68%	-11.22%	1.50%
Profit Margin	5.05%	2.39%	-4.18%	-3.51%	-5.88%	0.51%
FCF Margin	2.67%	7.99%	8.40%	12.48%	0.74%	9.12%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	38.91	54.97	-	-	-	67.35
Forward PE	18.75	15.04	11.69	11.92	2.71	5.65
P/FCF Ratio	78.41	16.43	10.45	6.23	18.49	3.75
PS Ratio	2.09	1.31	0.88	0.78	0.14	0.34